307 related articles for article (PubMed ID: 2818874)
1. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.
Coggin JH
Mol Biother; 1989; 1(4):223-8. PubMed ID: 2818874
[TBL] [Abstract][Full Text] [Related]
2. Cross-reacting antigens in chemically induced sarcomas are fetal determinants.
Parker GA; Rosenberg SA
J Immunol; 1977 May; 118(5):1590-4. PubMed ID: 67142
[TBL] [Abstract][Full Text] [Related]
3. Loss of marrow allograft resistance in mice with transplanted methylcholanthrene-induced sarcomas.
Kumar V; Bennett M
J Natl Cancer Inst; 1975 Aug; 55(2):489-92. PubMed ID: 240033
[TBL] [Abstract][Full Text] [Related]
4. The soluble antigens of BALB/c sarcoma Meth-A: a relationship between a serologically defined tumor-specific surface antigen (TSSA) and the tumor-associated transplantation antigen (TATA).
DuBois GC; Appella E; Law LW; DeLeo AB; Old LJ
Transplant Proc; 1981 Dec; 13(4):1765-73. PubMed ID: 6173944
[No Abstract] [Full Text] [Related]
5. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
Leffell MS; Coggin JH
Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
[No Abstract] [Full Text] [Related]
6. CD4+ T-cells from mice immunized to syngeneic sarcomas recognize distinct, non-shared tumor antigens.
Cohen PA; Cohen PJ; Rosenberg SA; Mulé JJ
Cancer Res; 1994 Feb; 54(4):1055-8. PubMed ID: 7906197
[TBL] [Abstract][Full Text] [Related]
7. Selective localization of radiolabeled immune lymphocytes into syngeneic tumors.
Mulé JJ; Jones FR; Hellström I; Hellström KE
J Immunol; 1979 Aug; 123(2):600-6. PubMed ID: 458150
[TBL] [Abstract][Full Text] [Related]
8. The serologic response to Meth A sarcoma vaccines after cyclophosphamide treatment is additionally increased by various adjuvants.
Livingston PO; Jones M; Deleo AB; Oettgen HF; Old LJ
J Immunol; 1985 Aug; 135(2):1505-9. PubMed ID: 4008930
[TBL] [Abstract][Full Text] [Related]
9. Immunogenic variants of a murine fibrosarcoma induced by mutagenesis: requirement of viable cells for antigen-specific cross-protection.
LeGrue SJ; Simcik WJ; Frost P
Cancer Res; 1987 Aug; 47(16):4413-6. PubMed ID: 3607772
[TBL] [Abstract][Full Text] [Related]
10. Changes in tumor-specific antigen expression during passage in vitro and in vivo of newly derived methylcholanthrene-induced sarcomas of BALB/C mice.
Law LW
Int J Cancer; 1980 Feb; 25(2):251-9. PubMed ID: 6156130
[TBL] [Abstract][Full Text] [Related]
11. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.
Kono K; Petersson M; Ciupitu AM; Wen T; Klein G; Kiessling R
Cancer Res; 1995 Dec; 55(23):5648-55. PubMed ID: 7585649
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens.
Kahan BD; Tanaka T; Pellis NR
J Natl Cancer Inst; 1980 Nov; 65(5):1001-4. PubMed ID: 6159495
[TBL] [Abstract][Full Text] [Related]
13. Differential recognition of murine tumor-associated oncofetal transplantation antigen and individually specific tumor transplantation antigens by syngeneic cloned BALB/c and RFM mouse T cells.
Rohrer JW; Rohrer SD; Barsoum A; Coggin JH
J Immunol; 1994 Jan; 152(2):754-64. PubMed ID: 7904290
[TBL] [Abstract][Full Text] [Related]
14. Cells from chemically induced mouse sarcomas retain tumor-specific transplantation antigenicity during prolonged passage in vitro.
Walker R; Hellström I; Hellström KE
Int J Cancer; 1980 Mar; 25(3):345-8. PubMed ID: 7390657
[TBL] [Abstract][Full Text] [Related]
15. Differential extraction of tumor-specific transplantation antigen and embryonic antigen from simian virus 40- and adenovirus 7-induced sarcoma cells of hamsters with 1-butanol and 3 M potassium chloride.
Coggin JH; Gillis LD; Payne WJ
J Natl Cancer Inst; 1984 Apr; 72(4):853-62. PubMed ID: 6323810
[TBL] [Abstract][Full Text] [Related]
16. Expression of a shared tumor-specific antigen by two chemically induced BALB/c sarcomas.
Palladino MA; Srivastava PK; Oettgen HF; DeLeo AB
Cancer Res; 1987 Oct; 47(19):5074-9. PubMed ID: 3497717
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immune reactions as probes of sensitization to tumour-associated antigens of methylcholanthrene-induced mouse sarcomas.
Bubeník J; Indrová M; Malkovský M; Símová J
Arch Geschwulstforsch; 1981; 51(4):349-53. PubMed ID: 6172086
[TBL] [Abstract][Full Text] [Related]
18. Cell surface antigens of chemically induced fibrosarcomas: detection by a monoclonal antibody of a tumor-restricted Mr 12,000 protein gag antigen encoded by a dual-tropic murine leukemia virus.
Carbone G; Pierotti MA; Boiocchi M; De Leo AB; Ballinari D; Radice P; Borrello MG; Meseguer A; Cernuschi A; Parmiani G
Cancer Res; 1985 Oct; 45(10):4980-5. PubMed ID: 2992769
[TBL] [Abstract][Full Text] [Related]
19. Generation of crossreacting tumor antigens in ascitic derivatives from murine methylcholanthrene-induced sarcomas.
Law LW
Int J Cancer; 1984 Apr; 33(4):547-51. PubMed ID: 6200449
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor lymph node cells from mice bearing methylcholanthrene-induced sarcomas.
Indrová M; Bubeník J
Neoplasma; 1979; 26(4):405-12. PubMed ID: 160510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
